# Scorpio NRG (eNeRGize) Cruciate Retaining (CR) Post-market International Outcome Study

> **NCT02524730** · NA · COMPLETED · sponsor: **Stryker Orthopaedics** · enrollment: 205 (actual)

## Conditions studied

- Arthroplasty, Replacement, Knee

## Interventions

- **DEVICE:** Primary total knee replacement (Scorpio NRG CR Total Knee System)

## Key facts

- **NCT ID:** NCT02524730
- **Lead sponsor:** Stryker Orthopaedics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05-18
- **Primary completion:** 2020-02-10
- **Final completion:** 2020-02-10
- **Target enrollment:** 205 (ACTUAL)
- **Last updated:** 2024-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02524730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02524730, "Scorpio NRG (eNeRGize) Cruciate Retaining (CR) Post-market International Outcome Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02524730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*